IP Library Granted Patent US 12,024,640
Granted Patent B2
US 12,024,640 · App. 17/504,019 · Granted Jul 2, 2024

UV-curing resin compositions for hard coat applications

Inventors: Michael Mulzer (Pickerington, OH); Kenneth Hernandez (Ashland, MA); Andrew Stella (Marlborough, MA); Lujia Bu (Southborough, MA); Jieqian Zhang (Southborough, MA); Deyan Wang (Hudson, MA); Yinjie Cen (Shrewsbury, MA)
Assignee: DUPONT ELECTRONICS INC.
C09D133/08C08K3/22C08K2003/2227
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,024,640
App. No.
17/504,019
Granted
Jul 2, 2024
Kind
B2
Abstract

Disclosed is an actinic radiation curable (meth)acrylic composition for use in hardcoats for optical displays containing one or more multifunctional (meth)acrylate monomers, one or more Si-containing (meth)acrylate monomers, one or more UV radical initiators, one or more monomers to improve surface cure, nanoparticles, and one or more organic solvents. Coated hardcoat articles made from this composition exhibit improved properties for use in display applications.

Claims (6)

1. An actinic radiation curable (meth)acrylic composition for use in hardcoats for optical displays comprising: (a) one or more multifunctional (meth)acrylate monomers; (b) one or more Si-containing (meth)acrylate monomers; (c) one or more UV radical initiators; (d) 0.5 to 5 wt. % of one or more monomers containing thiols selected from the group consisting of aliphatic thiols and aromatic thiols to improve surface cure; (e) nanoparticles, and (f) one or more organic solvents.

2. The actinic radiation curable (meth)acrylic composition of claim 1 ; wherein the one or more Si-containing (meth)acrylate monomers is selected from the group consisting of polyhedral oligomeric silsesquioxanes having one or more of the following Formula 1, Formula 2, Formula 3, Formula 4, and Formula 5:

wherein R is the same or different at each occurrence and is selected from the group consisting of hydrogen, deuterium, a halogen, a cyano, a substituted or unsubstituted perfluoro(C 1 -C 30 )alkyl, a partially fluorinated or perfluorinated polyether, a polyether derived from ethylene oxide, propylene oxide, tetrahydrofurane or analogous heterocycles, a substituted or unsubstituted (C 1 -C 30 )alkyl, a substituted or unsubstituted (C 1 -C 30 )alkyl, a substituted or unsubstituted deuterated (C 1 -C 30 )alkyl, a substituted or unsubstituted (C 2 -C 30 )alkenyl, a substituted or unsubstituted deuterated (C 2 -C 30 )alkenyl, a substituted or unsubstituted (C 2 -C 30 )alkynyl, a substituted or unsubstituted deuterated (C 2 -C 30 )alkynyl, a substituted or unsubstituted (C 3 -C 30 )cycloalkyl, a substituted or unsubstituted deuterated (C 3 -C 30 )cycloalkyl, a substituted or unsubstituted (C 6 -C 60 )aryl, a substituted or unsubstituted deuterated (C 6 -C 60 )aryl, a substituted or unsubstituted tri(C 1 -C 30 )alkylsilyl, a substituted or unsubstituted deuterated tri(C 1 -C 30 )alkylsilyl, a substituted or unsubstituted tri(C 6 -C 30 )arylsilyl, a substituted or unsubstituted deuterated tri(C 6 -C 30 )arylsilyl, a substituted or unsubstituted di(C 1 -C 30 )alkyl(C 6 -C 30 )arylsilyl, a substituted or unsubstituted deuterated di(C 1 -C 30 )alkyl(C 6 -C 30 )arylsilyl, a substituted or unsubstituted (C 1 -C 30 )alkyldi(C 6 -C 30 )arylsilyl, a substituted or unsubstituted deuterated (C 1 -C 30 )alkyldi(C 6 -C 30 )arylsilyl, a substituted or unsubstituted mono- or di-(C 6 -C 30 )arylamino, or a substituted or unsubstituted deuterated mono- or di-(C 6 -C 30 )arylamino; or may be linked to an adjacent substituent(s) to form a substituted or unsubstituted (C 3 -C 30 ), mono- or polycyclic, alicyclic or aromatic ring that may or may not contain deuterium, and whose carbon atom(s) may be replaced with at least one hetero atom selected from N, O, and S.

3. The actinic radiation curable (meth)acrylate composition of claim 2 ; wherein R is the same or different at each occurrence and contains one or more (meth)acrylate groups and one or more (meth)acrylate groups reacted with a thiol-compound comprising a substituted or unsubstituted (C 6 -C 30 )alkyl group.

4. The actinic radiation curable (meth)acrylic composition of claim 1 ; wherein the composition comprises from 0.05 to 2.5 wt. % of nanoparticles, and wherein the nanoparticles are selected from the group consisting of suspended silicon oxide nanoparticles and suspended aluminum oxide nanoparticles.

5. The actinic radiation curable (meth)acrylic composition of claim 1 ; wherein the one or more organic solvents is selected from the group consisting of ketones, ethers, aliphatic hydrocarbons, aromatic hydrocarbons; aromatic alcohols, alkanols, esters, and combinations thereof including combinations comprising multiple functional groups in the one or more organic solvents.

Assignments (3)
SECURITY INTEREST Recorded Nov 3, 2025
From: QNITY ELECTRONICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 073515/0243 →
SECURITY INTEREST Recorded Nov 3, 2025
From: QNITY ELECTRONICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 073517/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2021
From: HERNANDEZ, KENNETH; MULZER, MICHAEL; STELLA, ANDREW; BU, LUJIA; ZHANG, JIEQIAN; WANG, DEYAN; CEN, YINJIE
To: DUPONT ELECTRONICS, INC
Reel/Frame 058186/0748 →
Continuity (1)
Related Publication 20230124713A1 · Apr 20, 2023